GNTA
Genenta Science S.p.A.NASDAQHealthcare$0.71-4.90%ClosedMarket Cap: $13.6M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.91
P/S
0.00
EV/EBITDA
-1.58
DCF Value
$0.36
FCF Yield
-55.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-70.7%
ROA
-40.4%
ROIC
-43.2%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 2025 | $0.00 | NaN% | $-3.4M | $-3.8M | $-0.20 | — |
| Q4 2024 | $0.00 | NaN% | $-5.2M | $-4.9M | $-0.27 | — |
| FY 2024 | $0.00 | NaN% | $-9.8M | $-8.9M | $-0.49 | — |
| Q2 2024 | $0.00 | NaN% | $-4.5M | $-4.0M | $-0.22 | — |
| Q4 2023 | $0.00 | -Infinity% | $-4.9M | $-4.9M | $-0.27 | — |
| FY 2023 | $0.00 | -Infinity% | $-11.7M | $-11.6M | $-0.64 | — |
| Q2 2023 | $0.00 | -Infinity% | $-6.7M | $-6.7M | $-0.37 | — |
| Q4 2022 | $0.00 | NaN% | $-6.9M | $-6.4M | $-0.34 | — |
| FY 2022 | $0.00 | -Infinity% | $-11.0M | $-8.5M | $-0.47 | — |
| Q2 2022 | $0.00 | NaN% | $-4.2M | $-2.1M | $-0.12 | — |
| Q4 2021 | $0.00 | NaN% | $-1.6M | $-1.5M | $-0.10 | — |
| FY 2021 | $0.00 | -Infinity% | $-5.7M | $-5.5M | $-0.31 | — |